FDA Approves sBLA for Adalimumab-adaz as Interchangeable Biosimilar for Humira pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
AAM also elected Bob Hoffman, chief commercial officer of U.S. generics for Lupin, as vice chair of the board and Jeff Burd, president and CEO of North America of Ajanta Pharma USA, as treasurer.